It is possible to hypothesize that the observed down‐modulation of p21 by ZNF224 could lead to low expression levels of p21 relative to its physiological concentration, which then functions as a modulator of other oncogenic processes associated with the acquisition of aggressive tumor phenotype via p53‐independent mechanisms. Here, CDKN1A is linked to neoplasm.